These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6113285)

  • 21. Synthesis of heteroaromatic potential beta-adrenergic antagonists by the glycidol route.
    Antonio Y; Camargo C; Galeazzi E; Iriarte J; Guzman M; Muchowski JM; Gerrity K; Liu F; Miller LM; Strosberg MM
    J Med Chem; 1978 Jan; 21(1):123-6. PubMed ID: 22752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syntheses and beta-adrenergic blocking activities of the optical isomers of 8-acetonyloxyl-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril.
    Yo E; Nakagawa K; Hoshino Y
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2157-60. PubMed ID: 6119164
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adrenergic beta 1 and beta 2 blocking activity of new aminopropanols derived from oximes and esters].
    Rosell G; Mauleón D; Granados R; Selva C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):101-6. PubMed ID: 6151379
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and antiarrhythmic activity of new 1-[1-[2-[3-(alkylamino)-2-hydroxypropoxy]phenyl]vinyl]-1 H-imidazoles and related compounds.
    Ogata M; Matsumoto H; Takahashi K; Shimizu S; Kida S; Ueda M; Kimoto S; Haruna M
    J Med Chem; 1984 Sep; 27(9):1142-9. PubMed ID: 6147415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Adrenoceptor blocking activity of 3-alkylamino-1-(3-benzo[ b ]thienyloxy)-2-propanols and closely related bicyclic compounds.
    Conde S; Corral C; Lissavetzky J; Darias V; Galván O
    Arch Pharm (Weinheim); 1983 Jun; 316(6):537-44. PubMed ID: 6136264
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and structure-activity relationship of some new beta-blocking agents with possible alpha-adrenoreceptor activity.
    Bergmann J; Takács K
    Arch Pharm (Weinheim); 1990 Jul; 323(7):387-91. PubMed ID: 1978654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
    Lare MS; Smith LH
    J Med Chem; 1982 Nov; 25(11):1286-92. PubMed ID: 6128420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis of the highly cardioselective beta-sympatholytic pacrinolol].
    Stache U; Fritsch W; Fehlhaber HW
    Arzneimittelforschung; 1987 Nov; 37(11):1217-21. PubMed ID: 2894210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
    Baldwin JJ; Lumma WC; Lundell GF; Ponticello GS; Raab AW; Engelhardt EL; Hirschmann R; Sweet CS; Scriabine A
    J Med Chem; 1979 Nov; 22(11):1284-90. PubMed ID: 42797
    [No Abstract]   [Full Text] [Related]  

  • 30. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 31. Syntheses and beta-adrenergic blocking activities of carbostyril derivatives.
    Tominaga M; Tone H; Nakagawa K; Takada K; Hoshino Y; Watanabe K
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2166-81. PubMed ID: 6119165
    [No Abstract]   [Full Text] [Related]  

  • 32. Unambiguous synthesis of 1-(7-indenyloxy)-3-isopropylamino-2-propanol hydrochloride and its 4-indenyloxy isomer, potent beta-adrenergic blocking agents.
    Murase K; Tamazawa K; Mase T; Tachikawa S; Shiobara Y
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):552-4. PubMed ID: 14788
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity.
    Lis R; Morgan TK; Marisca AJ; Gomez RP; Lind JM; Davey DD; Phillips GB; Sullivan ME
    J Med Chem; 1990 Oct; 33(10):2883-91. PubMed ID: 1976812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis of 2-{3-[4-(4-fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}-phenylcarbamic acid alkylesters and in vitro evaluation of their beta-antiadrenergic and vasodilatative activities].
    Gonec T; Racanská E; Csöllei J
    Ceska Slov Farm; 2008 Jun; 57(3):115-8. PubMed ID: 18683428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 2-(N-substituted amino)-6-hydroxy-1,2,3,4-tetrahydronaphthalen-1-ol derivatives.
    Miyake A; Itoh K; Tada N; Tanabe M; Hirata M; Oka Y
    Chem Pharm Bull (Tokyo); 1983 Jul; 31(7):2329-48. PubMed ID: 6139177
    [No Abstract]   [Full Text] [Related]  

  • 40. A new series of tricyclic (aryloximino)propanolamines displaying very high selective beta 2-blocking properties.
    Jamart-Gregoire B; Caubere P; Blanc M; Gnassounou JP; Advenier C
    J Med Chem; 1989 Feb; 32(2):315-20. PubMed ID: 2563296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.